Sign in

CIK 0001730430

  • Large accelerated filer

Kiniksa Pharmaceuticals International, plc

Sign in to watch
Ticker
KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981795578
Phone
+1 781-431-9100
Business address
105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
Former names
Kiniksa Pharmaceuticals, Ltd.
  1. 4 Planned sale CHIEF MEDICAL OFFICER sold 400 shares at $17.53 ($7,012)
  2. 4 Open-market sale CHIEF MEDICAL OFFICER sold 29,000 shares at an average $19.14 ($555,160)
  3. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  9. 4 Grant or award Director acquired 17,492 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 291 shares (to pay taxes)
  17. 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 1,155 shares (to pay taxes)
  18. 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 1,353 shares (to pay taxes)
  19. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 734 shares (to pay taxes)
  20. 4 Shares withheld for taxes CHAIRMAN & CEO gave up 2,933 shares (to pay taxes)

Page 11 of 20 · 386 filings